腹腔CA3中的血清素受体4调节了阿戈梅拉丁诱导的抗焦虑类行为
Xiang-Hu Liu1, Muhammad Naveed1,2, Xiao-Yun Hu1
1Department of Clinical Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China.
Acta pharmacologica Sinica
|December 1, 2025
概括
阿戈梅拉丁通过降低小鼠腹部海马体 (vCA3) 中的5-HTR4表达的调节来减少焦虑. 这种机制涉及调节神经元活动,并突出了5-HTR4作为焦虑障碍的潜在目标.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 阿戈梅拉丁是一种非典型的抗抑郁药,具有抗焦虑性质.
- 了解阿戈梅拉丁抗焦虑作用的精确机制对于治疗情绪和焦虑障碍至关重要.
研究的目的:
- 为了研究底层的神经和分子机制的焦虑缓解作用的agomelatine.
- 为了确定特定的大脑区域和分子点,涉及到agomelatine的作用.
主要方法:
- 小鼠接受了慢性克制压力 (CRS),并接受了阿戈梅拉丁治疗.
- 使用OFT,EPM,TST和FT来评估与焦虑相关的行为.
- 使用c-Fos免疫组织化学和体内两光子成像测量神经元活动.
- 转录组测序和CRISPR-SpCas9技术被用于分析基因表达和功能.
主要成果:
- 阿戈梅拉丁的抗焦虑作用与海马体内腹部CA3 (vCA3) 区域中神经元活动的抑制有关.
- 转录组分析显示,阿戈梅拉丁降低了5-HTR4表达和其在vCA3.3中的信号通路的调节.
- 在vCA3中淘汰5-HTR4增加了类似焦虑的行为,证实了它的重要作用.
结论:
- 阿戈梅拉丁的抗焦虑作用是通过抑制vCA3.3中5-HTR4表达的介导.
- 这涉及神经元活动的调节和G蛋白合受体信号传递.
- 5-HTR4代表了焦虑障碍的潜在治疗标.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
857
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
857
Antidepressant Drugs: MAOIs and Other Agents
774
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
774
Anxiolytic Drugs: Overview
1.0K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.0K
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
G-protein Coupled Receptors
131.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.3K
Anxiolytic Drugs: Benzodiazepines and Buspirone
2.3K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.3K


